Author:
Schröder Hannsjörg,Wevers Andrea,Happich Elke,Schütz Ulrich,Moser Natasha,A.I. de Vos Robert,van Noort Gerard,Jansen Ernst N. H.,Giacobini Ezio,Maelicke Alfred
Reference10 articles.
1. Arneric SP, Sullivan JP, Decker MW, Brioni JD, Briggs CA, Donnelly-Roberts D, Marsh KC, Rodrigues AD, Garvey DS, Williams M, Buccafusco JJ (1994): ABT- 418: A novel cholinergic channel activator (ChCA) for the potential treatment of Alzheimer’s disease. In: Alzheimer Disease: Therapeutic Strategies, Giacobini E, R Becker, eds., Boston: Birkhäuser, pp. 196–200.
2. Court J, Piggott MA, Perry EK, Barlow RB, Perry RH (1992): Age associated decline in high affinity nicotine binding in human brain frontal cortex does not correlate with the changes in choline acetyltransferase activity. Neurosci Res Comm 10:125–133.
3. Court J, Clementi F (1995): Distribution of nicotinic subtypes in human brain. Alzheimer Dis Assoc Disorders 9 (Suppl. 2):6–14.
4. Moser N, Wevers A, Lorke DE, Reinhardt S, Maelicke A, Schröder H (1996): a4-l subunit mRNA of the nicotinic acetylcholine receptor in the rat olfactory bulb:cellular expression in adult, pre- and postnatal stages. Cell Tissue Res (in press)
5. Ostermann C-H, Grunwald J, Wevers A, Lorke DE, Reinhardt S, Maelicke A, Schröder H (1995): Cellular expression of a4 subunit mRNA of the nicotinic acetylcholine receptor in the developing rat telencephalon. Neurosci Lett 192:1–4.